This report presents the case of a woman aged 40 who has experienced premature menopause from the age of 35. Having rejected oocyte donation, she opted for intraovarian injection of autologous platelet-rich plasma with the aim to rejuvenate the ovarian tissue and enable the employment of her own gametes through in-vitro fertilization. Six weeks following the autologous platelet-rich plasma treatment, a significant reduction in the patient's follicle-stimulating hormone (FSH) levels were noted. A natural in-vitro fertilization cycle led to a biochemical pregnancy, resulting in a spontaneous abortion at the 5th week of pregnancy. This is the first report of a successful autologous platelet-rich plasma application leading to pregnancy in menopause. This report uniquely contributes to the medical knowledge and challenges current practice in the context of infertility. The efficiency and safety of this treatment with regard to the reproductive system merits further investigation.
Sfakianoudis, K., Simopoulou, M., Nitsos, N., Rapani, A., Pappas, A., Pantou, A., Koutsilieris, M., Pantos, K., Chronopoulou, M., & Deligeoroglou, E. (2018). Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause. *Journal of clinical medicine*, *8*(1), E1. https://doi.org/10.3390/jcm8010001
Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pappas A, Pantou A, et al. Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause. J Clin Med. 2018;8(1):E1. doi:10.3390/jcm8010001
Sfakianoudis, K., et al. "Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause." *Journal of clinical medicine*, vol. 8, no. 1, 2018, pp. E1.
Pantos K et al., 2019
Open Access
Cell Transplantation
Since the introduction of autologous platelet-rich plasma (PRP) in medical practice, various studies have documented that implementing PRP can enhance healing and the anti-aging process, employing ang...
Lu C et al., 2022
Open Access
Clinical and Translational Medicine
Premature ovarian insufficiency (POI) is a disorder of ovarian function, which occurs in approximately 3.7% of women younger than 40 years of age.1 The aetiologies of most cases were unknown and usual...
Delbaere I et al., 2020
Open Access
Upsala Journal of Medical Sciences
Delayed childbearing is currently a major challenge in reproductive medicine as increased age has an important impact on successful conception, both in natural and in assisted reproduction. There is a...